Business
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope – NEWS.com.au
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope
A participant in AstraZenecas coronavirus vaccine trial triggered a global shutdown of the promising vaccine after she experienced worrying neurological symptoms.The woman’s symptoms were consistent with transverse myelitis, a serious spinal inflammatory disorder that can cause bladder problems, muscle weakness, pain and at worst, paralysis.
AstraZeneca chief executive Pascal Soriot revealed the woman’s symptoms in a private conference call with investors yesterday, information that was later s…
-
General20 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News19 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General12 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News20 hours agoThe Best Things to Do in Brisbane This New Year’s Eve